Moran Wealth Management LLC Sells 2,570 Shares of Plexus Corp. $PLXS

Moran Wealth Management LLC cut its stake in Plexus Corp. (NASDAQ:PLXS) by 6.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 36,916 shares of the technology company’s stock after selling 2,570 shares during the quarter. Moran Wealth Management LLC owned 0.14% of Plexus worth $5,427,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently modified their holdings of PLXS. American Century Companies Inc. raised its stake in shares of Plexus by 44.2% in the third quarter. American Century Companies Inc. now owns 1,103,892 shares of the technology company’s stock worth $159,722,000 after purchasing an additional 338,119 shares during the last quarter. Balyasny Asset Management L.P. purchased a new stake in shares of Plexus in the third quarter worth approximately $12,509,000. Arrowstreet Capital Limited Partnership raised its stake in shares of Plexus by 965.0% in the third quarter. Arrowstreet Capital Limited Partnership now owns 80,890 shares of the technology company’s stock worth $11,704,000 after purchasing an additional 73,295 shares during the last quarter. Qube Research & Technologies Ltd raised its stake in shares of Plexus by 37.1% in the second quarter. Qube Research & Technologies Ltd now owns 242,726 shares of the technology company’s stock worth $32,843,000 after purchasing an additional 65,644 shares during the last quarter. Finally, Bank of America Corp DE raised its stake in shares of Plexus by 53.6% in the second quarter. Bank of America Corp DE now owns 177,237 shares of the technology company’s stock worth $23,982,000 after purchasing an additional 61,817 shares during the last quarter. 94.45% of the stock is owned by hedge funds and other institutional investors.

Plexus Stock Performance

Shares of PLXS opened at $228.64 on Friday. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 0.06. The company has a market capitalization of $6.13 billion, a price-to-earnings ratio of 35.56 and a beta of 0.75. The stock has a 50 day moving average of $203.58 and a 200 day moving average of $172.32. Plexus Corp. has a 12 month low of $115.35 and a 12 month high of $232.17.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, beating analysts’ consensus estimates of $1.77 by $0.01. The company had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.07 billion. Plexus had a return on equity of 12.39% and a net margin of 4.28%.Plexus’s revenue was up 9.6% on a year-over-year basis. During the same period last year, the business posted $1.73 earnings per share. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, sell-side analysts forecast that Plexus Corp. will post 5.9 earnings per share for the current year.

Trending Headlines about Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Plexus hit a fresh high on Nasdaq momentum, which can attract momentum traders and support near‑term upside. Plexus (NASDAQ:PLXS) Hits Fresh High Amid Nasdaq Composite Momentum
• Positive Sentiment: Plexus set its fiscal Q2 2026 earnings release for April 29 and will host a management call on April 30 — a near‑term catalyst that could reinforce the rally if results or guidance beat expectations. Plexus Sets Fiscal Second Quarter 2026 Earnings Release Date
• Neutral Sentiment: CEO Todd Kelsey sold 1,500 shares on April 15 under a pre‑arranged Rule 10b5‑1 plan; the sale is small relative to his remaining stake (~1.83% decrease) and typical of scheduled insider plans. Investors often view scheduled, plan‑based sales as neutral. SEC Filing – Form 4
• Negative Sentiment: Zacks Research downgraded Plexus from “strong‑buy” to “hold” and trimmed several near‑ and medium‑term EPS estimates (small reductions to FY2026–FY2028 and quarterly forecasts). The downgrade and estimate cuts can weigh on sentiment and analyst‑driven flows despite recent topline growth. Zacks Downgrade / Estimates

Insider Activity at Plexus

In related news, Director Karen Marie Rapp sold 500 shares of the stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $195.59, for a total transaction of $97,795.00. Following the completion of the sale, the director directly owned 8,535 shares of the company’s stock, valued at approximately $1,669,360.65. This trade represents a 5.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Frank Zycinski sold 1,399 shares of the stock in a transaction that occurred on Thursday, February 12th. The shares were sold at an average price of $205.99, for a total value of $288,180.01. The SEC filing for this sale provides additional information. Insiders sold a total of 50,995 shares of company stock valued at $10,345,971 in the last ninety days. Insiders own 1.78% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. Stifel Nicolaus increased their price objective on Plexus from $150.00 to $200.00 and gave the stock a “hold” rating in a research note on Friday, January 30th. Williams Trading set a $195.00 price objective on Plexus in a research note on Wednesday, January 28th. Zacks Research downgraded Plexus from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 13th. Needham & Company LLC increased their price objective on Plexus from $165.00 to $206.00 and gave the stock a “buy” rating in a research note on Friday, January 30th. Finally, Benchmark reissued a “buy” rating and issued a $220.00 price objective on shares of Plexus in a research note on Monday, March 16th. Three equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $194.20.

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.